Halozyme Therapeutics Inc. sell SVB Leerink LLC
Start price
13.05.25
/
50%
€48.64
Target price
13.05.26
€42.31
Performance (%)
23.85%
Price
20.02.26
€60.24
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 23.85%. This prediction currently runs until 13.05.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | -9.982% | -9.982% |
| iShares Core DAX® | 1.432% | 2.628% |
| iShares Nasdaq 100 | 1.892% | -0.458% |
| iShares Nikkei 225® | -1.619% | 11.097% |
| iShares S&P 500 | 1.921% | 1.159% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was downgraded by analysts at Leerink Partners from a "market perform" rating to an "underperform" rating. They now have a $47.00 price target on the stock.
Ratings data for HALO provided by MarketBeat